Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MYQOL conversion to Myfortic after renal transplantation
2004-005071-42Phase 4Completed
- Sponsor
- Novartis
- Start
- Mar 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of mycophenolate sodium in Kidney allograft status (RTx) (2 arms), sponsored by Novartis. Started Mar 2005; status: completed.
02
Drugs
mycophenolate sodium
03
Conditions
Kidney allograft status (RTx)
Beyond the preview
Go deeper on 2004-005071-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-005071-42.